Chronic Kidney Disease Surgery: Risks and Considerations

People with chronic kidney disease face roughly double to triple the odds of serious complications after surgery compared with people whose kidneys work normally, and the risk climbs steeply as kidney function declines. A large multi-specialty analysis of nearly two million surgical patients found that those with the most advanced kidney disease had about three times the odds of dying after an operation and more than three-and-a-half times the odds of a cardiac complication relative to patients with early-stage disease.¹ That does not mean surgery is off the table, but it does mean every phase of the process, from preoperative planning through recovery, requires adjustments that surgeons, anesthesiologists, and nephrologists must coordinate carefully.

How CKD Stage Shapes Surgical Risk

The relationship between kidney function and surgical outcomes is not a simple on-off switch. It follows a graded pattern: the worse the kidneys, the worse the outcomes. A systematic review and meta-analysis of studies on noncardiac surgery confirmed that CKD is an independent risk factor for postoperative death and cardiovascular events, with a strength of association comparable to that of diabetes, prior stroke, or coronary artery disease.² In practical terms, a person with moderately reduced kidney function already carries elevated risk, and someone on dialysis carries substantially more.

Cardiac surgery illustrates the gradient clearly. An analysis of over 2.7 million cardiac surgery admissions found in-hospital death rates of about 2.2% among patients with normal or near-normal kidney function, climbing to 3.7% with moderate CKD, 6.7% with advanced CKD, and 8.8% among patients with end-stage kidney disease requiring dialysis.³ For coronary artery bypass grafting specifically, each 10-unit drop in the kidney filtration rate has been linked to a 35–43% increase in the risk of operative death.⁴

The multi-specialty NSQIP analysis put more precise numbers on the broader surgical landscape: compared with stage 1 CKD, patients with stage 5 disease had adjusted odds ratios of about 2.1 for major complications, 3.0 for death, 1.6 for unplanned reoperation, 3.5 for cardiac complications, and 1.9 for stroke.¹ These numbers reinforce a message that matters for every surgical specialty: kidney function belongs in the risk conversation regardless of whether the surgery involves the kidneys.

Why Kidneys Make Surgery Harder

Several overlapping problems explain the elevated risk. The kidneys regulate fluid balance, blood pressure, electrolytes, acid-base status, and the clearance of waste products and drugs. When they falter, each of those jobs is partially undone, and surgery adds further stress. Blood flow to the kidneys can drop during anesthesia and surgery, and kidneys that are already compromised tolerate that reduction poorly.⁵ Even a temporary dip in blood flow can push a borderline kidney into acute injury.

The cardiovascular toll is equally important. CKD accelerates heart disease, stiffens blood vessels, and promotes fluid overload. Surgical patients with CKD are therefore more prone to heart attacks, dangerous heart rhythms, and heart failure during and after operations. Potassium imbalances are another concern. Impaired kidneys struggle to excrete potassium, and the levels can spike during surgery from tissue damage, blood transfusions, or certain anesthetic drugs. Elevated potassium is a direct threat to heart rhythm, so the perioperative team must monitor it closely and avoid fluids and medications that worsen the problem.

Bleeding Risks and Platelet Problems

Abnormal bleeding is a well-recognized hazard in advanced kidney disease. The primary culprit is platelet dysfunction: the platelets themselves do not activate and stick together properly, and their interaction with blood-vessel walls is impaired.⁶ This is partly caused by toxins that accumulate in the blood when the kidneys cannot clear them. Dialysis improves the situation but does not fully fix it.⁷

When bleeding becomes a problem, treatment options include desmopressin (a synthetic hormone that briefly boosts clotting ability) and conjugated estrogens for a longer-lasting effect. Maintaining a red blood cell level of at least 30% also helps, because red blood cells physically push platelets toward the vessel wall where they need to work.⁶ For surgeons, awareness of this bleeding tendency influences everything from the choice of procedure to how aggressively they use blood-thinning drugs afterward.

Anesthesia Adjustments

Anesthesia in CKD patients requires careful drug selection. Many of the muscle relaxants used during surgery are cleared by the kidneys, and when kidney function is reduced, those drugs linger in the body longer than expected. Pancuronium, vecuronium, and rocuronium all have a prolonged effect in kidney disease.⁸ The practical consequence is that a patient may take longer to regain normal muscle strength after surgery, delaying the ability to breathe independently. Atracurium and cisatracurium are safer alternatives because they break down in the bloodstream rather than relying on the kidneys.⁸

Beyond muscle relaxants, caution extends to pain drugs and sedatives used during anesthesia. Regional anesthesia (such as nerve blocks or epidurals) can sometimes be used to reduce the amount of systemic drugs needed, though the team must weigh this against the bleeding tendency discussed above.⁹ The overall goal is to choose agents that are metabolized independently of the kidneys or that can be dosed with a clear safety margin.

Blood Pressure Medications Before Surgery

Many CKD patients take drugs that block the renin-angiotensin system (commonly known as ACE inhibitors or ARBs) to protect their kidneys and control blood pressure. The standard recommendation is to hold these drugs roughly 24 hours before surgery, because they can cause prolonged drops in blood pressure once anesthesia is induced.¹⁰ The usual approach is to take the last dose the morning before the surgery date and restart once blood pressure is stable after the operation. An exception applies when the medication is keeping heart failure in check; stopping it abruptly could cause worse problems than the blood-pressure drop during surgery.

Other blood pressure drugs, diuretics, and diabetes medications each have their own stop-and-start rules that the surgical team reviews ahead of time. For CKD patients, who often take a long medication list, a thorough preoperative medication review is one of the most impactful safety steps.

Potassium, Fluids, and Intraoperative Monitoring

Managing fluids and electrolytes during surgery is more complicated in CKD. Patients with impaired kidneys are at high risk for elevated potassium, which can trigger life-threatening heart rhythms. Perioperative strategies to minimize that risk include using normal saline rather than lactated Ringer’s solution (which contains potassium), avoiding depolarizing muscle relaxants like succinylcholine that can release potassium from muscles, minimizing blood transfusions when possible, and keeping blood sugar well controlled in diabetic patients.⁸ Continuous heart monitoring during and after the operation helps catch early signs of potassium-related trouble.

Fluid management itself is a balancing act. Too little fluid during surgery reduces blood flow to the kidneys and worsens injury; too much leads to swelling, lung congestion, and heart strain in patients who cannot excrete the extra volume efficiently. The anesthesiologist aims for what is sometimes called “euvolemia,” the just-right zone where circulation stays adequate without overloading the system.

Laparoscopic Surgery and Kidney Pressure

Minimally invasive laparoscopic procedures are generally gentler on the body, but they carry a specific kidney-related quirk. The gas pumped into the abdomen to create working space raises pressure inside the belly. When that pressure exceeds about 10 mmHg, blood flow to the kidneys drops, urine output falls, and temporary kidney dysfunction can set in.¹¹ For people with healthy kidneys, these changes are typically reversible after the gas is released. For people with pre-existing CKD, though, the kidney can tip into acute injury.¹²

Strategies to protect the kidneys during laparoscopic surgery include keeping insufflation pressures as low as the surgeon can manage, giving generous intravenous fluids to offset the drop in kidney blood flow, and choosing patient positioning that minimizes the pressure effect. Animal studies have shown that aggressive fluid repletion can partially correct the decrease in kidney blood flow under laparoscopic conditions.¹² When a laparoscopic approach is planned for a CKD patient, the team often discusses in advance whether the benefits of smaller incisions and faster recovery outweigh the kidney-pressure risk.

Contrast Dye and Imaging

Preoperative and postoperative imaging often involves iodinated contrast dye, the liquid injected for CT scans and angiograms. There has long been concern that this dye damages already-vulnerable kidneys. The current consensus is that for patients with a filtration rate above about 30, the risk of contrast-related kidney injury is minimal.¹³ Below that threshold, preventive measures such as hydration with saline before and after the scan and using as little contrast as possible help reduce the risk.¹³

That said, when contrast-induced kidney injury does occur, the downstream effects can be serious: some patients need temporary dialysis, and there is a consistent association with higher rates of rehospitalization and death.¹⁴ A prospective study of patients undergoing major gastrointestinal surgery found that preoperative contrast exposure, after adjusting for other factors, was not itself associated with postoperative kidney injury.¹⁵ The takeaway for CKD patients is that contrast is not categorically forbidden, but the decision involves weighing how much kidney function is left, what alternatives exist (ultrasound, non-contrast MRI), and how critical the information from the contrast scan is to surgical planning.

Treating Pain After Surgery

Postoperative pain control is a minefield in CKD. Many common painkillers are cleared by the kidneys, and when they accumulate, side effects can be severe. Morphine and codeine are generally avoided because their breakdown products build up and can cause confusion, excessive sedation, and even seizures.¹⁶ Buprenorphine and fentanyl are considered safer first-line opioids in CKD, though fentanyl is not appropriate for patients on hemodialysis. Oxycodone and hydromorphone can be used with dose adjustments but are treated as second-line options in dialysis patients.¹⁶

Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are another common pitfall. They reduce blood flow to the kidneys and can trigger acute injury on top of chronic disease. Despite this, studies have found that standard-dose prescribing without accounting for kidney function remains common on medical and surgical wards, especially when CKD patients are cared for by teams not specialized in kidney disease.¹⁷ If you have CKD and are heading into surgery, asking your team specifically about which pain medications they plan to use, and whether doses have been adjusted for your kidney function, is a reasonable self-advocacy step.

Preparing for Surgery With Anemia

CKD commonly causes anemia because the kidneys produce less erythropoietin, the hormone that stimulates red blood cell production. Going into surgery anemic raises the chance you will need a blood transfusion, which itself carries risks: immune reactions, infections, and for anyone who may later need a kidney transplant, sensitization of the immune system that makes finding a compatible donor harder. A case report documented one approach to this problem: preoperative intravenous iron and erythropoietin given over several weeks boosted a patient’s hemoglobin by more than 2 grams per deciliter, allowing her to avoid transfusion entirely during a major abdominal surgery.¹⁸ Planning ahead to treat anemia before elective surgery is one of the most effective ways to reduce perioperative risk for CKD patients.

Dialysis Patients Face Extra Challenges

Patients already on dialysis sit at the extreme end of the risk spectrum, and existing surgical risk-assessment tools have not been properly validated in this population.¹⁹ The standard scoring systems used to predict surgical complications were developed in populations with functioning kidneys and fail to account for dialysis-specific variables like the timing of the last treatment, the type of vascular access, or the accumulated effects of years on dialysis.

Practical logistics matter too. Surgery should ideally be scheduled so that the patient has dialysis the day before but not the morning of the procedure, giving time to correct fluid and electrolyte levels without the bleeding risk that comes from the blood-thinning effects of the dialysis circuit. Protecting the vascular access site (the fistula or graft in the arm) during surgery is critical: no blood pressure cuffs, IVs, or blood draws from that arm. After surgery, the question of when to restart dialysis must be individualized. In patients who develop acute kidney injury on top of their chronic dialysis need, factors predicting an inability to wean off postoperative dialysis include older age, prolonged dialysis duration, and very low urine output in the first day after stopping.²⁰

When a Kidney Transplant Recipient Needs Unrelated Surgery

A growing number of surgical patients are people who received a kidney transplant years ago and now need an unrelated operation, whether it is a hip replacement, gallbladder removal, or heart bypass. These patients carry a unique double burden: the immunosuppressive drugs that keep their transplanted kidney alive also impair wound healing and infection resistance, and the transplanted kidney itself is vulnerable to injury during surgery. A meta-analysis found that kidney transplant recipients had roughly 2.2 times the odds of dying after cardiac or general surgery compared with non-transplanted patients. Acute kidney injury was the most common nonfatal complication, and the risk was highest after orthopedic surgery.²¹ Coordination with the transplant team to manage immunosuppressive drug levels around the operation is essential.

When Surgery May Not Be the Right Choice

For some patients with very advanced kidney disease, especially older adults with multiple health problems, the expected benefit of a surgical procedure may not outweigh the risks. This is where shared decision-making becomes critical. Frailty, which goes beyond age to capture overall physiological resilience, is a strong predictor of poor surgical outcomes. Screening tools and geriatric assessments can help identify patients who are unlikely to tolerate surgery well, guiding the conversation toward alternatives.²²

Conservative kidney management, meaning comfort-focused care without dialysis, is increasingly recognized as a legitimate path for patients with the most advanced CKD who are unlikely to benefit from aggressive interventions.²³ That same philosophy can extend to surgical decisions: a procedure that would be routine for a healthy person may become a high-stakes gamble in someone with advanced kidney disease and significant frailty. Having an honest conversation with a nephrologist and surgeon together, rather than consulting them in separate silos, tends to produce decisions that better reflect the patient’s actual goals.

Disparities in Surgical Access and Outcomes

Not everyone with CKD faces the same surgical landscape. Research on kidney-related surgery has uncovered racial and socioeconomic disparities in both the type of surgery offered and the results. In a study of patients with localized kidney tumors in New York City, Black patients were less likely than White patients to receive nephron-sparing surgery (the type that preserves more kidney tissue), and the gap was widest among patients in the highest socioeconomic brackets.²⁴ Separately, in an analysis of parathyroid surgery for a complication of CKD called secondary hyperparathyroidism, African American patients had higher rates of surgery than White patients but also trended toward more complications and longer hospital stays.²⁵

These patterns reflect broader issues in healthcare access, implicit bias, insurance coverage, and the geographic distribution of specialist centers. For individual patients, the practical implication is that seeking care at a center with experience managing CKD surgical patients and, when possible, requesting a multidisciplinary review that includes a nephrologist can help ensure the treatment plan is guided by kidney function rather than by zip code or demographics.

1
PubMed Central. Association of chronic kidney disease with postoperative outcomes: a national surgical quality improvement program (NSQIP) multi-specialty surgical cohort analysis
2
PubMed. Chronic kidney disease and postoperative mortality: a systematic review and meta-analysis
3
The Annals of Thoracic Surgery Short Reports. Association of Kidney Function With Inpatient Mortality and Morbidity After Cardiac Surgery
4
PubMed. Impact of chronic kidney disease on patient outcome following cardiac surgery
5
PubMed Central. Pathophysiology of acute kidney injury
6
PubMed. Platelet dysfunction and end-stage renal disease
7
PubMed. Platelet dysfunction in renal failure
8
PubMed Central. Navigating Anesthesia: Muscle Relaxants and Reversal Agents in Patients with Renal Impairment
9
PubMed. Anaesthesia for the patient with impaired renal function
10
Cardiovascular Prevention and Pharmacotherapy. Perioperative Management of Hypertensive Patients
11
PubMed Central. Renal implications of pneumoperitoneum in laparoscopic surgery: mechanisms, risk factors, and preventive strategies
12
NDT Plus. The risk of acute kidney injury following laparoscopic surgery in a chronic kidney disease patient
13
Journal of the Formosan Medical Association. Use of iodinated and gadolinium-based contrast media in patients with chronic kidney disease
14
PubMed. Contrast-Induced Acute Kidney Injury
15
BJS. Perioperative intravenous contrast administration and the incidence of acute kidney injury after major gastrointestinal surgery: prospective, multicentre cohort study
16
Therapeutics and Clinical Risk Management. Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists
17
PubMed Central. Management of acute and post-operative pain in chronic kidney disease
18
PubMed Central. Preoperative Intravenous Iron and Erythropoietin to Treat Severe Anemia in Patient With Stage 4 Kidney Disease Before Oncologic Surgery: A Case Report
19
PubMed. Perioperative outcomes and risk assessment in dialysis patients: current knowledge and future directions
20
PubMed. Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy
21
PubMed Central. Postoperative outcomes of kidney transplant recipients undergoing non-transplant-related elective surgery: a systematic review and meta-analysis
22
PubMed. Frailty and Renal Cell Carcinoma: Integration of Comprehensive Geriatric Assessment into Shared Decision-making
23
PubMed Central. Recommendations for the Care of Patients Receiving Conservative Kidney Management: Focus on Management of CKD and Symptoms
24
PubMed. Effects of race and socioeconomic status on treatment for localized renal masses in New York City
25
PubMed. Effects of Social Disparities on Management and Surgical Outcomes for Patients with Secondary Hyperparathyroidism